Eun Kyoung Choe, University of Maryland-College Park This pilot develops Aidara, an AI-powered digital health system that helps caregivers of individuals with cognitive impairments make safer over-the-counter medication decisions. Through multimodal interaction and personalized guidance, Aidara aims to support informed decision-making and reduce medication-related risks.
Gregory Stock, Socratic Sciences Inc. Hamed Zamani, University of Massachusetts. Mary Mittleman, New York University. Socratic Sciences, in collaboration with UMass and NYU, is developing an AI-facilitated, question-driven app to help family caregivers of those with AD/ADRD connect and support one another in small, trusted groups around open-ended questions. The project will test and refine a group-facilitation AI bot to make meaningful peer support scalable, accessible, and affordable for millions of overwhelmed caregivers.
Mariano I. Gabitto, Allen Institute This project seeks to develop and train a novel machine learning foundational model that unifies brain and peripheral immune system omics data to identify blood biomarkers and map cellular changes in AD/ADRD.
Felipe A. Jain, Massachusetts General Hospital, Finale Doshi-Velez, Harvard University. Family caregivers of people living with dementia have high needs for skills training and methods to reduce stress. This project will study the feasibility of a just-in-time adaptive intervention delivered by smartphone to increase engagement and helpfulness of caregiver skills and relaxation content for caregivers.
Tim K. Mackey, S-3 Research LLC, Joshua Yang, California State University, Fullerton. This project will aim to develop TrialChat, an AI-powered chatbot and clinical trial navigator designed to increase participation in Alzheimer’s disease and related dementias (ADRD) clinical trials by providing tailored education, personalized trial matching, and recruitment support for older adults and caregivers.
Jeremy Linsley, Operant BioPharma This project will use a proprietary robotics and artificial intelligence to identify targets and clinically-tested drugs that could be repurposed for Alzheimer's disease by blocking the harmful interaction between Tau and Amyloid Precursor proteins.
Gang Wang, University of Illinois at Urbana-Champaign. Roopa Foulger, OSF. This project will design, prototype, evaluate, and potentially deploy an AI-enabled voice agent to assist patients (especially older adults) to better recognize phishing messages and reduce cybersecurity risks during patient outreach and communications.